5.36
Panoramica
Notizia
Cronologia dei prezzi
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$5.43
Aprire:
$5.15
Volume 24 ore:
200.97K
Relative Volume:
0.31
Capitalizzazione di mercato:
$3.20M
Reddito:
-
Utile/perdita netta:
$-15.08M
Rapporto P/E:
-0.8349
EPS:
-6.42
Flusso di cassa netto:
$-11.56M
1 W Prestazione:
-11.70%
1M Prestazione:
+1.52%
6M Prestazione:
-63.09%
1 anno Prestazione:
-91.81%
Enveric Biosciences Inc Stock (ENVB) Company Profile
Nome
Enveric Biosciences Inc
Settore
Industria
Telefono
239-302-1707
Indirizzo
245 FIRST STREET RIVERVIEW II 18TH FLOOR, CAMBRIDGE
Confronta ENVB con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
|
ENVB
Enveric Biosciences Inc
|
5.36 | 3.24M | 0 | -15.08M | -11.56M | -6.42 |
|
VRTX
Vertex Pharmaceuticals Inc
|
455.71 | 114.69B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
752.62 | 77.91B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
850.95 | 54.05B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
391.50 | 52.52B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
196.92 | 42.02B | 447.02M | -1.18B | -906.14M | -6.1812 |
Enveric Biosciences Inc Borsa (ENVB) Ultime notizie
ENvue Medical (NASDAQ: FEED) taps veteran exec David Johnson as chairman - Stock Titan
Enveric Biosciences Announces Closing of Exercise of Warrants for $3.1 Million Gross Proceeds - pharmiweb.com
Enveric Biosciences raises $3.1 million through warrant exercise - Investing.com India
Enveric Biosciences Announces Exercise of Warrants for $3.1 Million Gross Proceeds - BioSpace
Enveric Biosciences (ENVB) Modifies Warrant Terms to Raise Funds - GuruFocus
Enveric Biosciences secures $3.1 million through warrant exercise By Investing.com - Investing.com Canada
Enveric Biosciences secures $3.1 million through warrant exercise - Investing.com
Enveric Biosciences shareholders approve stock issuance and share increase proposals - Investing.com
Enveric Biosciences Approves Key Stockholder Proposals - TipRanks
Enveric Biosciences skyrockets on patent allowance for psychedelic-inspired molecules - Mugglehead Magazine
Enveric Biosciences secures $3.1M through warrant exercise - MSN
Enveric Biosciences Inc. (ENVB) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Enveric Biosciences Stock Poised for Growth? - StocksToTrade
Top Biotech Stocks To ConsiderDecember 10th - MarketBeat
ENVB doubles after USPTO signals approval of key patent filing | Tap to know more | Inshorts - Inshorts
Why Did ENVB Stock More Than Double In Value Today? - Asianet Newsable
Enveric Biosciences: Anticipated Market Impact of New Patents - timothysykes.com
Enveric Biosciences stock soars after receiving patent allowance - Investing.com
Enveric Biosciences stock soars after receiving patent allowance By Investing.com - Investing.com Canada
Are Smart Investors Making the Right Decision? Enveric Biosciences Inc (ENVB) - setenews.com
Enveric Biosciences (ENVB) Stock Surges on Patent Win: News, Forecast & Analysis as of December 10, 2025 - ts2.tech
Top Pre‑Market Gainers Today, December 10, 2025: ASPC, ENVB, BDRX and APVO Lead Fed‑Day Frenzy - ts2.tech
What Sparked Enveric Biosciences (ENVB) 74% Surge In After-Hours Trading? - Sahm
Enveric Biosciences Receives Notice of Allowance for EVM301 Series of Drug Candidates - Investing News Network
Enveric Biosciences (ENVB) Gains Patent Approval for EVM301 Ment - GuruFocus
Enveric receives USPTO patent allowance for neuropsychiatric drug By Investing.com - Investing.com Canada
What analysts say about Enveric Biosciences Inc stockDividend Stability Analysis & Low Cost Portfolio Growth - earlytimes.in
Why Enveric Biosciences Inc. (SLZ) stock could outperform next yearEarnings Summary Report & High Yield Equity Trading Tips - Newser
Enveric Biosciences to Present at and Participate in Panel Discussion at Sachs Associates 9th Annual Neuroscience Innovation Forum During "J.P. Morgan Week 2026" - Yahoo Finance
A activity2025 Fundamental Recap & Weekly High Return Forecasts - Newser
Enveric Biosciences, Inc. (ENVB) Stock Price, News, Quote & History - Yahoo! Finance Canada
Will Enveric Biosciences Inc. (SLZ) stock top growth indexesBear Alert & Community Trade Idea Sharing - Newser
Enveric Biosciences (ENVB) Stock Analysis Report | Financials & Insights - Benzinga
How Enveric Biosciences Inc. (SLZ) stock stacks up against competitorsJuly 2025 Chart Watch & Precise Entry and Exit Recommendations - Newser
Enveric Biosciences (NASDAQ:ENVB) Shares Down 0.3% – Here’s What Happened - Defense World
Enveric Biosciences, Inc. (ENVB) -13.5% in After-hours: Stock Reacts After Recent Patent Allowance - Stocks Telegraph
Weekly Roundup on the Cannabis Sector & Psychedelic Sector - marketexclusive.com
Is the Smart Money Moving Into Sathlokhar Synergys E C Global Limited Institutional Buying TrendsMerger & Acquisition Updates & Free Stock Index Interpretations - earlytimes.in
Enveric Biosciences Receives Fourth Notice of Allowance for EVM401 Series of Drug Candidates - BioSpace
Enveric Biosciences (ENVB) Advances with Patent Allowance for EV - GuruFocus
Enveric Biosciences receives patent allowance for neuropsychiatric drugs By Investing.com - Investing.com Canada
Can Enveric Biosciences Inc. stock sustain institutional interestMarket Sentiment Report & Weekly Sector Rotation Insights - newser.com
Will Enveric Biosciences Inc. (SLZ) stock outperform global peersJuly 2025 Levels & Safe Capital Investment Plans - newser.com
Is Enveric Biosciences Inc. (SLZ) stock positioned for secular growthBull Run & Free Weekly Watchlist of Top Performers - newser.com
Is Enveric Biosciences Inc. (SLZ) stock considered safe havenMarket Movement Recap & Free Low Drawdown Momentum Trade Ideas - newser.com
How Enveric Biosciences Inc. stock performs in high volatility marketsJuly 2025 Movers & Reliable Volume Spike Alerts - newser.com
Enveric Biosciences Inc Azioni (ENVB) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):